Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors.
作者： Si-yu Ren , Zhen-zhen Wang , Yi Zhang , Nai-hong Chen
DOI: 10.1038/S41401-020-0385-7
关键词: Parkinson's disease 、 Pharmacology 、 Antidepressant 、 Anxiolytic 、 Neuroprotection 、 Monoacylglycerol lipase 、 Dopamine 、 Endocannabinoid system 、 Fatty acid amide hydrolase 、 Medicine
摘要: … is also the target of FAAH/MAGL inhibitors. In this review, we summarize … inhibitors in related neurological diseases. Focus on the latest research progress using FAAH/MAGL inhibitors …
chinaphar.com
nature.com参考文章(106)
Iván Manuel, Estíbaliz González de San Román, M. Teresa Giralt, Isidro Ferrer, Rafael Rodríguez-Puertas, Type-1 cannabinoid receptor activity during Alzheimer's disease progression Journal of Alzheimer's Disease. ,vol. 42, pp. 761- 766 ,(2014) , 10.3233/JAD-140492
N. Hlavacova, M. Chmelova, V. Danevova, A. Csanova, D. Jezova, Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats. Endocrine Regulations. ,vol. 49, pp. 131- ,(2015) , 10.4149/ENDO_2015_03_131
S Zoppi, J L Madrigal, J R Caso, M S García-Gutiérrez, J Manzanares, J C Leza, B García-Bueno, Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. British Journal of Pharmacology. ,vol. 171, pp. 2814- 2826 ,(2014) , 10.1111/BPH.12607
DM Kerr, B Harhen, BN Okine, LJ Egan, DP Finn, M Roche, The monoacylglycerol lipase inhibitor JZL184 attenuates LPS‐induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action British Journal of Pharmacology. ,vol. 169, pp. 808- 819 ,(2013) , 10.1111/J.1476-5381.2012.02237.X
Zhen Zhang, Wei Wang, Peng Zhong, Sarah J. Liu, Jonathan Z. Long, Li Zhao, Hai-qing Gao, Benjamin F. Cravatt, Qing-song Liu, Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity Hippocampus. ,vol. 25, pp. 16- 26 ,(2015) , 10.1002/HIPO.22344
Ross B. Mounsey, Sarah Mustafa, Lianne Robinson, Ruth A. Ross, Gernot Riedel, Roger G. Pertwee, Peter Teismann, Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Experimental Neurology. ,vol. 273, pp. 36- 44 ,(2015) , 10.1016/J.EXPNEUROL.2015.07.024
Cristina Benito, Estefanía Núñez, Rosa M. Tolón, Erica J. Carrier, Alberto Rábano, Cecilia J. Hillard, Julián Romero, Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains The Journal of Neuroscience. ,vol. 23, pp. 11136- 11141 ,(2003) , 10.1523/JNEUROSCI.23-35-11136.2003
Steven G. Kinsey, Scott T. O'Neal, Jonathan Z. Long, Benjamin F. Cravatt, Aron H. Lichtman, Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacology, Biochemistry and Behavior. ,vol. 98, pp. 21- 27 ,(2011) , 10.1016/J.PBB.2010.12.002
Katerina Otrubova, Cyrine Ezzili, Dale L. Boger, The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH) Bioorganic & Medicinal Chemistry Letters. ,vol. 21, pp. 4674- 4685 ,(2011) , 10.1016/J.BMCL.2011.06.096
K. Yaragudri Vinod, Basalingappa L. Hungund, Role of the endocannabinoid system in depression and suicide Trends in Pharmacological Sciences. ,vol. 27, pp. 539- 545 ,(2006) , 10.1016/J.TIPS.2006.08.006